搜尋結果
2023年11月7日 · VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) — TELUS Health today unveiled its latest innovation, a next-generation Medical Alert Pendant – a discreet wearable device specifically designed to empower older adults to confidently age
2024年3月18日 · MELBOURNE, Australia, March 18, 2024 (GLOBE NEWSWIRE) — One of the greatest and most exciting players in tennis history has partnered with Pepperstone, with former World No. 1 and seven-time grand slam singles champion John McEnroe joining forces with the globally recognised Forex (FX) and Contracts for Difference (CFD) broker.
1 天前 · Denver, Colorado, May 29, 2024 (GLOBE NEWSWIRE) — Asal Shokati, Ayurvedic practitioner and a certified yoga and meditation teacher, is working to bring awareness on the benefits Ayurveda can have on understanding inflammatory and autoimmune diseases. According to Asal, it is recognized in Ayurveda that organs represent certain emotions and ...
2024年4月9日 · HONG KONG SAR – Media OutReach Newswire – 9 April 2024 – AS Watson is pleased to announce the promotion of Malina Ngai to Group CEO, effective from 1st May 2024. HONG KONG SAR – Media OutReach Newswire – 9 April 2024 – AS Watson is pleased to announce the promotion of Malina Ngai to Group CEO, effective from 1 st May 2024.
2023年10月16日 · New Method Wellness, a leading substance abuse treatment center located in Southern California, is thrilled to announce it’s now in-network with TriWest Healthcare Alliance. San Juan Capistrano, California, May 15, 2024 — New Method Wellness, a leading substance abuse treatment center located in Southern California, is thrilled to
2023年7月24日 · 07月24日 15:56 美通社. HSBC takes the top spot in the inaugural Kantar BrandZ Hong Kong Top 30 Brands Ranking. The report was produced in partnership between Kantar and Design Bridge and Partners. HONG KONG, July 24, 2023 /PRNewswire/ — Global bank HSBC has landed the top spot in WPP global design agency Design Bridge and Partners and ...
2024年3月20日 · TRYVIO (aprocitentan) is an endothelin receptor antagonist that inhibits the binding of endothelin (ET)-1 to ET A and ET B receptors. 1,2 The effects of ET-1 bear many similarities with the pathophysiology of hypertension, 3 and ET-1 is a major driver of aldosterone production. 4 Until the approval of TRYVIO, no systemic antihypertensive medications targeted the ET pathway, 5 as approved ...
